KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Staar Surgical (STAA) over the last 13 years, with Q3 2025 value amounting to $376000.0.

  • Staar Surgical's Treasury Shares fell 4726.51% to $376000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $376000.0, marking a year-over-year decrease of 4726.51%. This contributed to the annual value of $401000.0 for FY2023, which is 10885.42% up from last year.
  • According to the latest figures from Q3 2025, Staar Surgical's Treasury Shares is $6.5 million.
  • Over the past 5 years, Staar Surgical's Treasury Shares peaked at $1.5 million during Q1 2025, and registered a low of -$261000.0 during Q2 2025.
  • Moreover, its 5-year median value for Treasury Shares was $199000.0 (2022), whereas its average is $348947.4.
  • As far as peak fluctuations go, Staar Surgical's Treasury Shares skyrocketed by 11428.57% in 2024, and later plummeted by 13707.39% in 2025.
  • Over the past 5 years, Staar Surgical's Treasury Shares (Quarter) stood at $131000.0 in 2021, then skyrocketed by 46.56% to $192000.0 in 2022, then surged by 108.85% to $401000.0 in 2023, then soared by 77.81% to $713000.0 in 2024, then plummeted by 47.27% to $376000.0 in 2025.
  • Its Treasury Shares stands at $376000.0 for Q3 2025, versus -$261000.0 for Q2 2025 and $1.5 million for Q1 2025.